Management of Cancer-Associated Venous Thromboembolism in the Emergency Department
- 1 June 2017
- journal article
- review article
- Published by Elsevier BV in Annals of Emergency Medicine
- Vol. 69 (6), 768-776
- https://doi.org/10.1016/j.annemergmed.2016.12.003
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Management of challenging cases of patients with cancer‐associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2013
- CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patientsBMC Cancer, 2013
- Apixaban for Extended Treatment of Venous ThromboembolismThe New England Journal of Medicine, 2013
- Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesClinicoEconomics and Outcomes Research, 2013
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United StatesCancer, 2012
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-AnalysisPLoS Medicine, 2012
- Epidemiology of cancer-related venous thromboembolismBest Practice & Research Clinical Haematology, 2009
- Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic reviewJournal of Experimental & Clinical Cancer Research, 2008
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Therapy of venous thromboembolism in patients with brain metastasesCancer, 1994